Member Info for GloriaMarket

This RNS should reenforce the resistance levels. Investors are less likely to sell based on todays RNS. Traders however, will sell as this RNS has not delivered them the profit they hoped for. I've filtered Mr Carrots but I wouldn't be surprised if he's already sold. I imagine John Henry has sold this morning too @ 3.2p

Mr Franky, that's a fair summary. GDR has definitely turned a corner but it's an unfortunate situation, yet a familiar one, in that GDR's products do NOT sell themselves, despite what the LSE ramper kings may think.

"am I right in thing FDA could land at anytime?"

311 days on average according to breakthrough website. Usually it takes 365 days or so.

"Wes Streeting will be announcing his masterstroke on savings within the NHS soon !"

Yes , now the tories can no longer offer contracts to their friends and family, GDR stands a chance.

"Do you ever take a day off StockSaint?"

https://i0.wp.com/boingboing.net/wp-content/uploads/2016/10/8FMIkmn.jpg?fit=1&ssl=1&resize=620%2C4000

Rampers! This is the face of the enemy.... https://i0.wp.com/boingboing.net/wp-content/uploads/2016/10/8FMIkmn.jpg?fit=1&ssl=1&resize=620%2C4000

"Sales are only going to go up from here, ALONG WITH THE SHARE PRICE ;-)"

yes, sp currently up 3.8%

Sell on news they say... 3.23p

One really good thing is that we know greater manchester will use their test kit, and probably use it alot, based on the recommendations publicly given by the Professors.

"Genedrive® System is also suitable for traditional laboratory testing paradigms as a more affordable alternative to more expensive laboratory platforms where sample throughput requirements do not necessitate high-scale batch processing."

Dr Gino hits the nail on the head. A single lab test is more expensive than GDR's POC kit, only a certain number of tests in a batch make lab tests more economical (love to know how many).

Sales RNSes always welcome. Really curious to see how the market reacts to this RNS.

"money in the bank for around 18 months depending how dales improve"

And with that statement of pure hope not fact, MrGordenGecko123 confirms he's so insecure about his investment in GDR that he NEEDS people to read his comment and be persuaded to buy GDR shares .

I have no agenda. Not invested at the moment so a rise or fall in sp doesn't affect my bank balance whatsoever.

*fairytale rampers

"All it is very well having partnerships, but what all of us wants to see is an RNS saying we have XX millions orders. That will shut the derampers up, once for all."

It certainly would! But as long as GDR requires dilutions to remain an ongoing concern, derampers deserve respect as their predictions prove tobe farmore accurate than the fairytales rapers enjoy telling.

"Gloria your assumptions are amateurish you make no allowance for increased revenue and reduction in cash burn ."

I base my assumptions on what the company tells us in their meetings and Rnses and certainly not what rampy short-termers think.

Thinking about it, I imagine mr cheek had a 12 month contract and was told before end of july that it will not be renewed. Which means he receive payment for august and that's all.

Mr carrots, yiu only say its a screaming buy because you sold at 4p and bought back in at 3.2p. When u sell at 3.8p itll be a screaming sell. Ive decided to block you as you have nothing to add to the discussion but your own agenda.

I recall at a general meeting mr cheek saying something a long the lines of finding out why gdr could not sell AIHL. One of the reason was that the instructions for the kit had not been translate into local languages. During mr cheeks tenue as ceo he focussed on removing barriers to sales. It had minimal effect, or at least not a large enough effect. It does make me wonder why a scientist as ceo would have more success then a seasoned salesman who has a track record of selling products to the NHS. The worst case scenario is similar to GDR's covid test products.. complete lack of interest in the market. Which is why they need to provide training and give the kits out for

free in some sort of sales drive. First 100 hospitals to call get the kits free of charge.

*2025!

"With a yearly cashburn of 3.5M"

The most recent rns stated the cashburn was 420k per month (thats 5M per year). However, the company expected cashburnto increase and by 3025 it will be 600k per month. Cashburn is far higher than you think. Who knows what the cashburn is now after FDA breakthrough programme and the NICE full recommendation. Its probably Increased due to extra work involve in daling with FDA and selling to NHS.

" you got to give them time it doesn’t happen overnight"

Correct and the clock is ticking.. Dr Miele has about 6 months before cash runs out, perhaps less. And then GDR will probably dilute the SP again. It's a huge risk to invest in GDR. However, trading in GDR is far less risky.